• Real Time Chart Real Time Chart
  • Stock Profile Stock Profile
  • Financials As Reported

    • accession Number 0001326110-23-000064
    • accounts Payable Current 33,573,000
    • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 73,415,000
    • accumulated Other Comprehensive Income Loss Net Of Tax --33,000
    • allocated Share Based Compensation Expense 10,878,000
    • amendment Flag false
    • assets 343,400,000
    • assets Current 113,486,000
    • cash And Cash Equivalents At Carrying Value 88,481,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --16,160,000
    • cik 1,326,110
    • city Area Code 844
    • common Stock Par Or Stated Value Per Share 0.0001
    • common Stock Shares Authorized 900,000,000
    • common Stock Shares Issued 435,923,104
    • common Stock Shares Outstanding 421,569,115
    • current Fiscal Year End Date --12-31
    • date Filed 2023-05-11
    • depreciation 4,200,000
    • depreciation Depletion And Amortization 4,681,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic -0.27
    • earnings Per Share Diluted -0.27
    • entity Address Address Line 1 3530 John Hopkins Court
    • entity Address City Or Town San Diego
    • entity Address Postal Zip Code 92,121
    • entity Address State Or Province CA
    • entity Central Index Key 1,326,110
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 001-37507
    • entity Filer Category Non-accelerated Filer
    • entity Incorporation State Country Code DE
    • entity Interactive Data Current Yes
    • entity Name ImmunityBio, Inc.
    • entity Registrant Name IMMUNITYBIO, INC.
    • entity Shell Company false
    • entity Small Business true
    • entity Tax Identification Number 43-1979754
    • finance Lease Liability 122,000
    • finance Lease Liability Current 79,000
    • finance Lease Liability Current Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilitiesCurrent
    • finance Lease Liability Noncurrent 43,000
    • finance Lease Liability Noncurrent Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
    • finance Lease Liability Payments Due 132,000
    • finance Lease Liability Payments Due Next Twelve Months 66,000
    • finance Lease Liability Payments Due Year Four 0
    • finance Lease Liability Payments Due Year Three 0
    • finance Lease Liability Payments Due Year Two 0
    • finance Lease Liability Undiscounted Excess Amount 10,000
    • finance Lease Right Of Use Asset 115,000
    • finance Lease Right Of Use Asset Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
    • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --116,583,000
    • income Taxes Paid Net 0
    • income Tax Expense Benefit 0
    • interest Expense 29,816,000
    • interest Paid Net 15,515,000
    • irs Number 431,979,754
    • lessee Operating Lease Liability Payments Due 72,758,000
    • lessee Operating Lease Liability Payments Due Next Twelve Months 12,119,000
    • lessee Operating Lease Liability Payments Due Year Four 8,209,000
    • lessee Operating Lease Liability Payments Due Year Three 10,290,000
    • lessee Operating Lease Liability Payments Due Year Two 12,145,000
    • lessee Operating Lease Liability Undiscounted Excess Amount 20,684,000
    • liabilities 875,116,000
    • liabilities And Stockholders Equity 343,400,000
    • liabilities Current 564,945,000
    • local Phone Number 696-5235
    • marketable Securities Current 2,787,000
    • marketable Securities Noncurrent 820,000
    • net Cash Provided By Used In Financing Activities 76,888,000
    • net Cash Provided By Used In Investing Activities --8,484,000
    • net Cash Provided By Used In Operating Activities --84,300,000
    • net Income Loss --116,343,000
    • nonoperating Income Expense --5,003,000
    • operating Expenses 111,940,000
    • operating Income Loss --111,580,000
    • operating Lease Cost 2,921,000
    • operating Lease Liability 49,133,000
    • operating Lease Liability Current 2,844,000
    • operating Lease Liability Noncurrent 46,289,000
    • operating Lease Payments 3,179,000
    • operating Lease Right Of Use Asset 44,191,000
    • other Assets Current 4,428,000
    • other Assets Noncurrent 4,545,000
    • other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax --226,000
    • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent --116,559,000
    • other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax --6,000
    • other Liabilities Noncurrent 462,000
    • other Nonoperating Income Expense --1,077,000
    • payments Related To Tax Withholding For Share Based Compensation 357,000
    • payments To Acquire Property Plant And Equipment 8,428,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 0
    • property Plant And Equipment Gross 227,580,000
    • property Plant And Equipment Net 154,165,000
    • report Link https://www.sec.gov/Archives/edgar/data/1326110/000132611023000064/ibrx-20230331_htm.xml
    • research And Development Expense 79,264,000
    • retained Earnings Accumulated Deficit --2,500,000,000
    • selling General And Administrative Expense 32,676,000
    • share Based Compensation 10,878,000
    • stockholders Equity --528,983,000
    • trading Symbol IBRX
    • update 1970-01-01
    • variable Lease Cost 970,000
    • weighted Average Number Of Diluted Shares Outstanding 428,381,485
    • weighted Average Number Of Shares Outstanding Basic 428,381,485
    • id REPORTED_FINANCIALS
    • key IBRX
    • subkey 10-Q
    • date 2023-05-11
    • updated 2023-05-12
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

IBRX stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001326110-23-000064
  • accounts Payable Current 33,573,000
  • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 73,415,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --33,000
  • allocated Share Based Compensation Expense 10,878,000
  • amendment Flag false
  • assets 343,400,000
  • assets Current 113,486,000
  • cash And Cash Equivalents At Carrying Value 88,481,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --16,160,000
  • cik 1,326,110
  • city Area Code 844
  • common Stock Par Or Stated Value Per Share 0.0001
  • common Stock Shares Authorized 900,000,000
  • common Stock Shares Issued 435,923,104
  • common Stock Shares Outstanding 421,569,115
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-11
  • depreciation 4,200,000
  • depreciation Depletion And Amortization 4,681,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic -0.27
  • earnings Per Share Diluted -0.27
  • entity Address Address Line 1 3530 John Hopkins Court
  • entity Address City Or Town San Diego
  • entity Address Postal Zip Code 92,121
  • entity Address State Or Province CA
  • entity Central Index Key 1,326,110
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-37507
  • entity Filer Category Non-accelerated Filer
  • entity Incorporation State Country Code DE
  • entity Interactive Data Current Yes
  • entity Name ImmunityBio, Inc.
  • entity Registrant Name IMMUNITYBIO, INC.
  • entity Shell Company false
  • entity Small Business true
  • entity Tax Identification Number 43-1979754
  • finance Lease Liability 122,000
  • finance Lease Liability Current 79,000
  • finance Lease Liability Current Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#AccountsPayableAndOtherAccruedLiabilitiesCurrent
  • finance Lease Liability Noncurrent 43,000
  • finance Lease Liability Noncurrent Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
  • finance Lease Liability Payments Due 132,000
  • finance Lease Liability Payments Due Next Twelve Months 66,000
  • finance Lease Liability Payments Due Year Four 0
  • finance Lease Liability Payments Due Year Three 0
  • finance Lease Liability Payments Due Year Two 0
  • finance Lease Liability Undiscounted Excess Amount 10,000
  • finance Lease Right Of Use Asset 115,000
  • finance Lease Right Of Use Asset Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
  • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --116,583,000
  • income Taxes Paid Net 0
  • income Tax Expense Benefit 0
  • interest Expense 29,816,000
  • interest Paid Net 15,515,000
  • irs Number 431,979,754
  • lessee Operating Lease Liability Payments Due 72,758,000
  • lessee Operating Lease Liability Payments Due Next Twelve Months 12,119,000
  • lessee Operating Lease Liability Payments Due Year Four 8,209,000
  • lessee Operating Lease Liability Payments Due Year Three 10,290,000
  • lessee Operating Lease Liability Payments Due Year Two 12,145,000
  • lessee Operating Lease Liability Undiscounted Excess Amount 20,684,000
  • liabilities 875,116,000
  • liabilities And Stockholders Equity 343,400,000
  • liabilities Current 564,945,000
  • local Phone Number 696-5235
  • marketable Securities Current 2,787,000
  • marketable Securities Noncurrent 820,000
  • net Cash Provided By Used In Financing Activities 76,888,000
  • net Cash Provided By Used In Investing Activities --8,484,000
  • net Cash Provided By Used In Operating Activities --84,300,000
  • net Income Loss --116,343,000
  • nonoperating Income Expense --5,003,000
  • operating Expenses 111,940,000
  • operating Income Loss --111,580,000
  • operating Lease Cost 2,921,000
  • operating Lease Liability 49,133,000
  • operating Lease Liability Current 2,844,000
  • operating Lease Liability Noncurrent 46,289,000
  • operating Lease Payments 3,179,000
  • operating Lease Right Of Use Asset 44,191,000
  • other Assets Current 4,428,000
  • other Assets Noncurrent 4,545,000
  • other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax --226,000
  • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent --116,559,000
  • other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax --6,000
  • other Liabilities Noncurrent 462,000
  • other Nonoperating Income Expense --1,077,000
  • payments Related To Tax Withholding For Share Based Compensation 357,000
  • payments To Acquire Property Plant And Equipment 8,428,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 0
  • property Plant And Equipment Gross 227,580,000
  • property Plant And Equipment Net 154,165,000
  • report Link https://www.sec.gov/Archives/edgar/data/1326110/000132611023000064/ibrx-20230331_htm.xml
  • research And Development Expense 79,264,000
  • retained Earnings Accumulated Deficit --2,500,000,000
  • selling General And Administrative Expense 32,676,000
  • share Based Compensation 10,878,000
  • stockholders Equity --528,983,000
  • trading Symbol IBRX
  • update 1970-01-01
  • variable Lease Cost 970,000
  • weighted Average Number Of Diluted Shares Outstanding 428,381,485
  • weighted Average Number Of Shares Outstanding Basic 428,381,485
  • id REPORTED_FINANCIALS
  • key IBRX
  • subkey 10-Q
  • date 2023-05-11
  • updated 2023-05-12